RETATRUTIDE 10mg
EXPRESS Apple Pay afterpay
Clearly documented laboratory results.
Retatrutide at a glance
One compound. Three receptor pathways.
Retatrutide’s defining research characteristic is its ability to engage three signalling pathways within a single molecule. Investigators study how these receptor systems interact in metabolic regulation. The summaries below describe receptor biology, not established effects of the product supplied by Halo Bio.
Glucagon-like peptide-1
A receptor pathway involved in glucose-dependent insulin signalling, digestive regulation and satiety signalling.
Glucose-dependent insulinotropic polypeptide
An incretin pathway investigated for its role in insulin responses and metabolic signalling.
Glucagon receptor
A receptor associated with hepatic metabolic signalling and energy-substrate regulation.
The pharmacology of a triple-receptor agonist cannot be inferred simply by adding together the properties of three separately administered compounds.
What has been studied?
Research into Retatrutide includes laboratory pharmacology, earlier clinical development and large controlled clinical trials. These studies investigate an investigational medicinal formulation in monitored research settings; they are not tests of Halo Bio stock.
Phase 2 ยท New England Journal of Medicine (2023)
A randomised study examined Retatrutide across several investigational groups and reported changes in body weight and safety outcomes over 48 weeks. These findings supported continued investigation rather than establishing suitability for individual use.
TRIUMPH-1 ยท New England Journal of Medicine (2026)
The Phase 3 study assessed Retatrutide against placebo over 80 weeks in adults with obesity without diabetes, reporting both efficacy and adverse-event findings. Trial observations do not establish the quality, equivalence or clinical performance of independently supplied research material.
Retatrutide, Tirzepatide & Semaglutide
These are distinct molecules with different receptor targets. The comparison below describes receptor activity only; it is not a ranking of safety or effectiveness.
| Compound | GLP-1 | GIP | Glucagon |
|---|---|---|---|
| Retatrutide | Yes | Yes | Yes |
| Tirzepatide | Yes | Yes | No |
| Semaglutide | Yes | No | No |
Comparisons between trial results require attention to different study populations, endpoints and follow-up periods. Separate studies are not direct head-to-head comparisons.
Melbourne stock. Nationwide dispatch.
Halo Bio holds stock in Melbourne and offers same-day dispatch on eligible orders placed before 2pm on business days, following payment confirmation. Shipping estimates and tracking information are provided during fulfilment. Dispatch timing is not a guarantee of delivery time.
Retatrutide research FAQs
What is Retatrutide?
Retatrutide (LY3437943) is an investigational molecule designed to activate GLP-1, GIP and glucagon receptors.
What does โTriple Gโ mean?
It is an informal name referring to the molecule’s three receptor targets. It does not mean the vial contains three separate compounds.
How is Retatrutide different from Tirzepatide?
Retatrutide has activity at three receptor types, while Tirzepatide targets GLP-1 and GIP. The two are distinct molecules.
What does the 10mg label mean?
It identifies the vial’s nominal labelled content. Actual measured content for a submitted sample is presented separately in the laboratory report.
What does HPLC test?
High-performance liquid chromatography can be used to assess chromatographic purity and, with an appropriate validated method, quantitative content.
What does LC-MS identity testing tell us?
Liquid chromatographyโmass spectrometry provides analytical evidence relevant to identifying a compound in the submitted sample. Interpretation depends on the method and report.
Can I independently view Halo Bio’s COA?
Yes. The public LabDoc reference is LD-FSYV. Check the exact batch and test details on the official record.
Does a COA mean every vial was tested?
No. A COA ordinarily describes a particular submitted sample or batch. It does not establish that every individual vial was separately analysed.
How quickly are eligible orders dispatched?
Halo Bio offers same-day dispatch from Melbourne on eligible orders submitted before 2pm on business days, subject to stock availability and payment confirmation.
Is this research material intended for personal use?
No. Halo Bio supplies this material for laboratory research only, not human or animal consumption or clinical use.
Independent publications & documentation
- Jastreboff AM et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity โ Phase 2 Trial. N Engl J Med, 2023. Study โ
- Jastreboff AM et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity โ TRIUMPH-1. N Engl J Med, 2026. Study โ
- LabDoc independent sample record: LD-FSYV. View report โ
